Journal
CLINICAL AND TRANSLATIONAL MEDICINE
Volume 3, Issue -, Pages -Publisher
SPRINGEROPEN
DOI: 10.1186/2001-1326-3-15
Keywords
Induced pluripotent stem cells; Embryonic stem cells; Differentiation and characterization; Lung stem/progenitor cells; Lung tissue engineering
Categories
Funding
- U.S. Public Health Service National Institutes Health [R21 HL102833-01]
- University Texas Medical School Bridging Grant Program
- Welch Foundation Endowment Fund [7712]
Ask authors/readers for more resources
Lung possesses very limited regenerative capacity. Failure to maintain homeostasis of lung epithelial cell populations has been implicated in the development of many life-threatening pulmonary diseases leading to substantial morbidity and mortality worldwide, and currently there is no known cure for these end-stage pulmonary diseases. Embryonic stem cells (ESCs) and somatic cell-derived induced pluripotent stem cells (iPSCs) possess unlimited self-renewal capacity and great potential to differentiate to various cell types of three embryonic germ layers (ectodermal, mesodermal, and endodermal). Therapeutic use of human ESC/iPSC-derived lung progenitor cells for regeneration of injured or diseased lungs will have an enormous clinical impact. This article provides an overview of recent advances in research on pluripotent stem cells in lung tissue regeneration and discusses technical challenges that must be overcome for their clinical applications in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available